IEQ Capital’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Buy
109,762
+88,776
+423% +$244K ﹤0.01% 1454
2026
Q1
$28.1K Buy
+20,986
New +$41.8K ﹤0.01% 1860
2025
Q4
Sell
-18,100
Closed -$121K 2012
2025
Q3
$121K Buy
18,100
+397
+2% +$2.59K ﹤0.01% 1747
2025
Q2
$104K Buy
17,703
+4,480
+34% +$29.2K ﹤0.01% 1712
2025
Q1
$111K Buy
+13,223
New +$119K ﹤0.01% 1462

Other funds holding TMCI

IEQ Capital's TMCI Position: Q2 2026 in Review

IEQ Capital increased its Treace Medical Concepts (TMCI) stake by 423% in Q2 2026, buying an estimated $244K and bringing the position to 109,762 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

IEQ Capital first reported a position in TMCI in Q1 2025 and has held it in 5 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • IEQ Capital held 109,762 shares of Treace Medical Concepts worth $437K as of Q2 2026.
  • IEQ Capital bought 88,776 Treace Medical Concepts shares in Q2 2026, an estimated $244K.
  • Treace Medical Concepts made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1454 holding.
  • IEQ Capital first reported a position in Treace Medical Concepts in Q1 2025 and has held it in 5 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.